211 related articles for article (PubMed ID: 21227392)
1. Multiplexed methylation profiles of tumor suppressor genes in bladder cancer.
Cabello MJ; Grau L; Franco N; Orenes E; Alvarez M; Blanca A; Heredero O; Palacios A; Urrutia M; Fernández JM; López-Beltrán A; Sánchez-Carbayo M
J Mol Diagn; 2011 Jan; 13(1):29-40. PubMed ID: 21227392
[TBL] [Abstract][Full Text] [Related]
2. Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study.
García-Baquero R; Puerta P; Beltran M; Alvarez M; Sacristan R; Alvarez-Ossorio JL; Sánchez-Carbayo M
J Urol; 2013 Aug; 190(2):723-30. PubMed ID: 23485510
[TBL] [Abstract][Full Text] [Related]
3. Molecular classification of non-muscle-invasive bladder cancer (pTa low-grade, pT1 low-grade, and pT1 high-grade subgroups) using methylation of tumor-suppressor genes.
Sacristan R; Gonzalez C; Fernández-Gómez JM; Fresno F; Escaf S; Sánchez-Carbayo M
J Mol Diagn; 2014 Sep; 16(5):564-572. PubMed ID: 24998186
[TBL] [Abstract][Full Text] [Related]
4. Methylation of tumor suppressor genes in a novel panel predicts clinical outcome in paraffin-embedded bladder tumors.
García-Baquero R; Puerta P; Beltran M; Alvarez-Mújica M; Alvarez-Ossorio JL; Sánchez-Carbayo M
Tumour Biol; 2014 Jun; 35(6):5777-86. PubMed ID: 24577895
[TBL] [Abstract][Full Text] [Related]
5. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer.
Castro M; Grau L; Puerta P; Gimenez L; Venditti J; Quadrelli S; Sánchez-Carbayo M
J Transl Med; 2010 Sep; 8():86. PubMed ID: 20849603
[TBL] [Abstract][Full Text] [Related]
6. Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.
Gurioli G; Salvi S; Martignano F; Foca F; Gunelli R; Costantini M; Cicchetti G; De Giorgi U; Sbarba PD; Calistri D; Casadio V
J Transl Med; 2016 Aug; 14(1):249. PubMed ID: 27576364
[TBL] [Abstract][Full Text] [Related]
7. Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine.
Chen PC; Tsai MH; Yip SK; Jou YC; Ng CF; Chen Y; Wang X; Huang W; Tung CL; Chen GC; Huang MM; Tong JH; Song EJ; Chang DC; Hsu CD; To KF; Shen CH; Chan MW
BMC Med Genomics; 2011 May; 4():45. PubMed ID: 21599969
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Guérin response in patients with T1G3 high-risk bladder tumours.
Agundez M; Grau L; Palou J; Algaba F; Villavicencio H; Sanchez-Carbayo M
Eur Urol; 2011 Jul; 60(1):131-40. PubMed ID: 21514719
[TBL] [Abstract][Full Text] [Related]
9. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma.
Chen K; Sawhney R; Khan M; Benninger MS; Hou Z; Sethi S; Stephen JK; Worsham MJ
Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1131-8. PubMed ID: 18025318
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection.
Negraes PD; Favaro FP; Camargo JL; Oliveira ML; Goldberg J; Rainho CA; Salvadori DM
BMC Cancer; 2008 Aug; 8():238. PubMed ID: 18702824
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.
Renard I; Joniau S; van Cleynenbreugel B; Collette C; Naômé C; Vlassenbroeck I; Nicolas H; de Leval J; Straub J; Van Criekinge W; Hamida W; Hellel M; Thomas A; de Leval L; Bierau K; Waltregny D
Eur Urol; 2010 Jul; 58(1):96-104. PubMed ID: 19674832
[TBL] [Abstract][Full Text] [Related]
13. A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.
Zuiverloon TC; Beukers W; van der Keur KA; Munoz JR; Bangma CH; Lingsma HF; Eijkemans MJ; Schouten JP; Zwarthoff EC
BJU Int; 2012 Mar; 109(6):941-8. PubMed ID: 21756281
[TBL] [Abstract][Full Text] [Related]
14. Improved Noninvasive Bladder Cancer Diagnosis using Urine Sediments and Novel DNA Methylation Biomarker Panels.
Wang K; Tian Y; Xu H
Clin Lab; 2016; 62(3):327-36. PubMed ID: 27156320
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
Roperch JP; Grandchamp B; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Cussenot O; Incitti R
BMC Cancer; 2016 Sep; 16(1):704. PubMed ID: 27586786
[TBL] [Abstract][Full Text] [Related]
16. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel.
Dulaimi E; Uzzo RG; Greenberg RE; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Mar; 10(6):1887-93. PubMed ID: 15041703
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach.
Casadio V; Molinari C; Calistri D; Tebaldi M; Gunelli R; Serra L; Falcini F; Zingaretti C; Silvestrini R; Amadori D; Zoli W
J Exp Clin Cancer Res; 2013 Nov; 32(1):94. PubMed ID: 24252461
[TBL] [Abstract][Full Text] [Related]
18. A two-gene methylation signature for the diagnosis of bladder cancer in urine.
Bosschieter J; Nieuwenhuijzen JA; Hentschel A; van Splunter AP; Segerink LI; Vis AN; Wilting SM; Lissenberg-Witte BI; A van Moorselaar RJ; Steenbergen RD
Epigenomics; 2019 Feb; 11(3):337-347. PubMed ID: 30706728
[TBL] [Abstract][Full Text] [Related]
19. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
[TBL] [Abstract][Full Text] [Related]
20. A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
Hermanns T; Savio AJ; Olkhov-Mitsel E; Mari A; Wettstein MS; Saba K; Bhindi B; Kuk C; Poyet C; Wild PJ; Noon A; Bashir S; Juvet T; Rendon RA; Waltregny D; van der Kwast T; Finelli A; Kulkarni GS; Fleshner NE; Lo K; Bapat B; Zlotta AR
Urol Oncol; 2020 Jun; 38(6):603.e1-603.e7. PubMed ID: 32081560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
